[Immunological supervision and carcinogenesis].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D000939:Epitopes; D005838:Genotype; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007125:Immunogenetics; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009369:Neoplasms / Q000276:immunology*; D009858:Oncogenic Viruses / Q000276:immunology; D011830:Radiation Effects; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors; D014181:Transplantation Immunology
D000961:Antilymphocyte Serum; D002273:Carcinogens; D000939:Epitopes; D007166:Immunosuppressive Agents
Immunologicheskiĭ nadzor i kantserogenez